针灸治疗2型糖尿病:21项随机对照试验的系统评价与Meta分析
该系统评价纳入21项RCT(n=1,188),比较针灸联合降糖药与单用降糖药治疗T2DM。Meta分析显示针灸组空腹血糖(MD -6.46 mg/dL,95%CI -11.95至-0.98;中等质量证据)和HOMA-IR(MD -1.23,95%CI -2.16至-0.31;低质量证据)下降更显著,但HbA1c、2hBG和FINS变化无统计学差异。针灸相关不良事件均为轻度,安全性良好。
要点
- 针灸联合降糖药可小幅降低空腹血糖,证据质量中等。
- 针灸可能改善胰岛素抵抗(HOMA-IR下降),但证据质量低。
- 对HbA1c、2hBG和FINS的效应尚不确定,需更多长期证据。
核心结论
- 针灸作为降糖药的辅助治疗,对降低空腹血糖和改善胰岛素抵抗有小的但统计学显著的效应。
- 针灸对HbA1c、2hBG和FINS的效应仍不确定,针灸在轻度糖尿病患者中总体安全。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase、Cochrane Library和ClinicalTrials.gov至2020年7月。
- 纳入21项随机对照试验,共1,188例2型糖尿病患者,比较针灸联合降糖药与单用降糖药。
主要发现
- 针灸组空腹血糖下降更显著(MD -6.46 mg/dL,95%CI -11.95至-0.98;中等质量证据)。
- 针灸组HOMA-IR下降更显著(MD -1.23,95%CI -2.16至-0.31;低质量证据)。
- HbA1c变化无统计学差异(MD -0.39%,95%CI -0.84至1.61;极低质量证据)。
- 2hBG变化无统计学差异(MD -4.99 mg/dL,95%CI -20.74至10.76;低质量证据)。
- FINS变化无统计学差异(MD -1.32 µIU/mL,95%CI -3.76至1.12;低质量证据)。
关键数值与推荐
- 主要结局为HbA1c和空腹血糖,次要结局包括2hBG、FINS、HOMA-IR和针灸相关不良事件。
- 所有报告的针灸相关不良事件均为轻度。
- 未发现糖尿病并发症发生率的数据。
临床怎么用
- 针灸可作为降糖药的辅助疗法,用于辅助降低空腹血糖和改善胰岛素抵抗。
- 对HbA1c、2hBG和FINS的改善作用不明确,不应作为主要治疗目标。
- 在轻度糖尿病患者中针灸安全性良好,但仍需监测不良事件。
局限性
- HbA1c结局的证据质量极低,2hBG、FINS和HOMA-IR的证据质量低。
- 缺乏糖尿病并发症发生率的数据。
- 需要更多长期效应的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects of acupuncture on hypoglycaemic outcomes in type 2 diabetes mellitus (T2DM). METHODS: PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched from inception up to July 2020, to identify randomised controlled trials (RCTs) that enrolled patients with T2DM and compared acupuncture combined with antidiabetic drugs to antidiabetic drugs alone. The primary outcomes were haemoglobin A1c (HbA1c) and fasting blood glucose (FBG). The secondary outcomes included 2-h blood glucose (2hBG), fasting insulin (FINS), homeostatic model assessment for insulin resistance (HOMA-IR), and acupuncture-related adverse events. Mean difference (MD) and 95% confidence interval (CI) were used as the effect measure in the meta-analysis. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation tool. RESULTS: Twenty-one RCTs (n=1,188) were included. The meta-analytic results showed that the acupuncture group had greater reductions in FBG (MD -6.46 mg/dL, 95% CI -11.95 to -0.98; moderate-quality evidence) and HOMA-IR (MD -1.23, 95% CI -2.16 to -0.31; low-quality evidence), but comparable changes in HbA1c (MD -0.39%, 95% CI -0.84 to 1.61; very-low-quality evidence), 2hBG (MD -4.99 mg/dL, 95% CI -20.74 to 10.76; low-quality evidence), and FINS (MD -1.32 µIU/mL, 95% CI -3.76 to 1.12; low-quality evidence). No data on the incidence of diabetic complications were found. All acupuncture-related adverse events reported were mild. CONCLUSIONS: The current evidence suggests that acupuncture, as a complementary therapy to antidiabetic drugs, has a small but statistically significant effect on decreasing FBG and improving insulin resistance. The effects of acupuncture on HbA1c, 2hBG, and FINS remain uncertain. Acupuncture is generally safe in patients with mild diabetes. More evidence for the long-term effects of acupuncture on T2DM is needed. (Trial registration No. CRD42018115639).
引用
- Li SQ, Chen JR, Liu ML, et al. Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials. Chin J Integr Med. 2021. PMID: 34432205. doi:10.1007/s11655-021-3450-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。